 | • レポートコード：QFJ1-5481 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、肺チップの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺炎症、肺感染症）、用途別市場規模（製薬・バイオテクノロジー企業、学術・研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肺チップの市場動向 ・企業の競争状況、市場シェア ・肺チップの種類別市場規模と予測2016-2027（肺炎症、肺感染症） ・肺チップの用途別市場規模と予測2016-2027（製薬・バイオテクノロジー企業、学術・研究所、その他） ・肺チップの北米市場規模2016-2027（アメリカ、カナダ） ・肺チップの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺チップのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺チップの中南米市場規模2016-2027（メキシコ、ブラジル） ・肺チップの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Emulate、Tissuse、Hesperos、CN Bio Innovations、Draper Laboratory、Mimetas、Nortis、Kirkstall、Cherry Biotech SAS、Else Else Kooi Laboratory、Micronit Microtechnologies B.V.） ・結論 |
Lung on a chip. The device is made using human lung and blood vessel cells and it can predict absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. It can be used to test the effects of environmental toxins, absorption of aerosolized therapeutics, and the safety and efficacy of new drugs.
In 2021, the global Lung-on-a-chip market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Lung-on-a-chip status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Lung-on-a-chip development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Lung-on-a-chip Scope and Market Size
Lung-on-a-chip market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung-on-a-chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pulmonary Inflammation
Pulmonary Infection
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung-on-a-chip Market Size Growth Rate by Type (2021-2027)
1.2.2 Pulmonary Inflammation
1.2.3 Pulmonary Infection
1.3 Market by Application
1.3.1 Global Lung-on-a-chip Market Share by Application (2021-2027)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lung-on-a-chip Market Size
2.2 Lung-on-a-chip Market Size by Regions
2.2.1 Lung-on-a-chip Growth Rate by Regions (2021-2027)
2.2.2 Lung-on-a-chip Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Lung-on-a-chip Revenue by Players (2020-2021)
3.2 Lung-on-a-chip Key Players Headquaters and Area Served
3.3 Key Players Lung-on-a-chip Product/Solution/Service
3.4 Date of Enter into Lung-on-a-chip Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Lung-on-a-chip Market Size by Type (2021-2027)
4.2 Global Lung-on-a-chip Market Size by Application (2021-2027)
5 North America
5.1 North America Lung-on-a-chip Market Forecast (2021-2027)
5.2 Lung-on-a-chip Key Players in North America
5.3 North America Lung-on-a-chip Market Size by Type
5.4 North America Lung-on-a-chip Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Lung-on-a-chip Market Forecast (2021-2027)
6.2 Lung-on-a-chip Key Players in Europe
6.3 Europe Lung-on-a-chip Market Size by Type
6.4 Europe Lung-on-a-chip Market Size by Application
7 Japan
7.1 Japan Lung-on-a-chip Market Forecast (2021-2027)
7.2 Lung-on-a-chip Key Players in Europe
7.3 Japan Lung-on-a-chip Market Size by Type
7.4 Japan Lung-on-a-chip Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Lung-on-a-chip Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Lung-on-a-chip Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Lung-on-a-chip Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Emulate
9.1.1 Emulate Company Details
9.1.2 Emulate Description and Business Overview
9.1.3 Emulate Lung-on-a-chip Introduction
9.1.4 Emulate Revenue in Lung-on-a-chip Business (2020-2021)
9.1.5 Emulate Recent Development
9.2 Tissuse
9.2.1 Tissuse Company Details
9.2.2 Tissuse Description and Business Overview
9.2.3 Tissuse Lung-on-a-chip Introduction
9.2.4 Tissuse Revenue in Lung-on-a-chip Business (2020-2021)
9.2.5 Tissuse Recent Development
9.3 Hesperos
9.3.1 Hesperos Company Details
9.3.2 Hesperos Description and Business Overview
9.3.3 Hesperos Lung-on-a-chip Introduction
9.3.4 Hesperos Revenue in Lung-on-a-chip Business (2020-2021)
9.3.5 Hesperos Recent Development
9.4 CN Bio Innovations
9.4.1 CN Bio Innovations Company Details
9.4.2 CN Bio Innovations Description and Business Overview
9.4.3 CN Bio Innovations Lung-on-a-chip Introduction
9.4.4 CN Bio Innovations Revenue in Lung-on-a-chip Business (2020-2021)
9.4.5 CN Bio Innovations Recent Development
9.5 Draper Laboratory
9.5.1 Draper Laboratory Company Details
9.5.2 Draper Laboratory Description and Business Overview
9.5.3 Draper Laboratory Lung-on-a-chip Introduction
9.5.4 Draper Laboratory Revenue in Lung-on-a-chip Business (2020-2021)
9.5.5 Draper Laboratory Recent Development
9.6 Mimetas
9.6.1 Mimetas Company Details
9.6.2 Mimetas Description and Business Overview
9.6.3 Mimetas Lung-on-a-chip Introduction
9.6.4 Mimetas Revenue in Lung-on-a-chip Business (2020-2021)
9.6.5 Mimetas Recent Development
9.7 Nortis
9.7.1 Nortis Company Details
9.7.2 Nortis Description and Business Overview
9.7.3 Nortis Lung-on-a-chip Introduction
9.7.4 Nortis Revenue in Lung-on-a-chip Business (2020-2021)
9.7.5 Nortis Recent Development
9.8 Kirkstall
9.8.1 Kirkstall Company Details
9.8.2 Kirkstall Description and Business Overview
9.8.3 Kirkstall Lung-on-a-chip Introduction
9.8.4 Kirkstall Revenue in Lung-on-a-chip Business (2020-2021)
9.8.5 Kirkstall Recent Development
9.9 Cherry Biotech SAS
9.9.1 Cherry Biotech SAS Company Details
9.9.2 Cherry Biotech SAS Description and Business Overview
9.9.3 Cherry Biotech SAS Lung-on-a-chip Introduction
9.9.4 Cherry Biotech SAS Revenue in Lung-on-a-chip Business (2020-2021)
9.9.5 Cherry Biotech SAS Recent Development
9.10 Else Else Kooi Laboratory
9.10.1 Else Else Kooi Laboratory Company Details
9.10.2 Else Else Kooi Laboratory Description and Business Overview
9.10.3 Else Else Kooi Laboratory Lung-on-a-chip Introduction
9.10.4 Else Else Kooi Laboratory Revenue in Lung-on-a-chip Business (2020-2021)
9.10.5 Else Else Kooi Laboratory Recent Development
9.11 Micronit Microtechnologies B.V.
9.11.1 Micronit Microtechnologies B.V. Company Details
9.11.2 Micronit Microtechnologies B.V. Description and Business Overview
9.11.3 Micronit Microtechnologies B.V. Lung-on-a-chip Introduction
9.11.4 Micronit Microtechnologies B.V. Revenue in Lung-on-a-chip Business (2020-2021)
9.11.5 Micronit Microtechnologies B.V. Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Lung-on-a-chip Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Pulmonary Inflammation
Table 3. Key Players of Pulmonary Infection
Table 4. Global Lung-on-a-chip Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global Lung-on-a-chip Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global Lung-on-a-chip Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global Lung-on-a-chip Revenue by Players (2020-2021) (US$ Million)
Table 10. Global Lung-on-a-chip Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players Lung-on-a-chip Product Solution and Service
Table 13. Date of Enter into Lung-on-a-chip Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global Lung-on-a-chip Market Size by Type (2021-2027) (US$ Million)
Table 16. Global Lung-on-a-chip Market Size Share by Type (2021-2027)
Table 17. Global Lung-on-a-chip Market Size by Application (2021-2027) (US$ Million)
Table 18. Global Lung-on-a-chip Market Size Share by Application (2021-2027)
Table 19. North America Key Players Lung-on-a-chip Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players Lung-on-a-chip Market Share (2020-2021)
Table 21. North America Lung-on-a-chip Market Size by Type (2021-2027) (US$ Million)
Table 22. North America Lung-on-a-chip Market Share by Type (2021-2027)
Table 23. North America Lung-on-a-chip Market Size by Application (2021-2027) (US$ Million)
Table 24. North America Lung-on-a-chip Market Share by Application (2021-2027)
Table 25. Europe Key Players Lung-on-a-chip Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players Lung-on-a-chip Market Share (2020-2021)
Table 27. Europe Lung-on-a-chip Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe Lung-on-a-chip Market Share by Type (2021-2027)
Table 29. Europe Lung-on-a-chip Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe Lung-on-a-chip Market Share by Application (2021-2027)
Table 31. Japan Key Players Lung-on-a-chip Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players Lung-on-a-chip Market Share (2020-2021)
Table 33. Japan Lung-on-a-chip Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan Lung-on-a-chip Market Share by Type (2021-2027)
Table 35. Japan Lung-on-a-chip Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan Lung-on-a-chip Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Emulate Company Details
Table 41. Emulate Description and Business Overview
Table 42. Emulate Lung-on-a-chip Product
Table 43. Emulate Revenue in Lung-on-a-chip Business 2020 and 2021
Table 44. Emulate Recent Development
Table 45. Tissuse Company Details
Table 46. Tissuse Description and Business Overview
Table 47. Tissuse Lung-on-a-chip Product
Table 48. Tissuse Revenue in Lung-on-a-chip Business 2020 and 2021
Table 49. Tissuse Recent Development
Table 50. Hesperos Company Details
Table 51. Hesperos Description and Business Overview
Table 52. Hesperos Lung-on-a-chip Product
Table 53. Hesperos Revenue in Lung-on-a-chip Business 2020 and 2021
Table 54. Hesperos Recent Development
Table 55. CN Bio Innovations Company Details
Table 56. CN Bio Innovations Description and Business Overview
Table 57. CN Bio Innovations Lung-on-a-chip Product
Table 58. CN Bio Innovations Revenue in Lung-on-a-chip Business 2020 and 2021
Table 59. CN Bio Innovations Recent Development
Table 60. Draper Laboratory Company Details
Table 61. Draper Laboratory Description and Business Overview
Table 62. Draper Laboratory Lung-on-a-chip Product
Table 63. Draper Laboratory Revenue in Lung-on-a-chip Business 2020 and 2021
Table 64. Draper Laboratory Recent Development
Table 65. Mimetas Company Details
Table 66. Mimetas Description and Business Overview
Table 67. Mimetas Lung-on-a-chip Product
Table 68. Mimetas Revenue in Lung-on-a-chip Business 2020 and 2021
Table 69. Mimetas Recent Development
Table 70. Nortis Company Details
Table 71. Nortis Description and Business Overview
Table 72. Nortis Lung-on-a-chip Product
Table 73. Nortis Revenue in Lung-on-a-chip Business 2020 and 2021
Table 74. Nortis Recent Development
Table 75. Kirkstall Company Details
Table 76. Kirkstall Description and Business Overview
Table 77. Kirkstall Lung-on-a-chip Product
Table 78. Kirkstall Revenue in Lung-on-a-chip Business 2020 and 2021
Table 79. Kirkstall Recent Development
Table 80. Cherry Biotech SAS Company Details
Table 81. Cherry Biotech SAS Description and Business Overview
Table 82. Cherry Biotech SAS Lung-on-a-chip Product
Table 83. Cherry Biotech SAS Revenue in Lung-on-a-chip Business 2020 and 2021
Table 84. Cherry Biotech SAS Recent Development
Table 85. Else Else Kooi Laboratory Company Details
Table 86. Else Else Kooi Laboratory Description and Business Overview
Table 87. Else Else Kooi Laboratory Lung-on-a-chip Product
Table 88. Else Else Kooi Laboratory Revenue in Lung-on-a-chip Business 2020 and 2021
Table 89. Else Else Kooi Laboratory Recent Development
Table 90. Micronit Microtechnologies B.V. Company Details
Table 91. Micronit Microtechnologies B.V. Description and Business Overview
Table 92. Micronit Microtechnologies B.V. Lung-on-a-chip Product
Table 93. Micronit Microtechnologies B.V. Revenue in Lung-on-a-chip Business 2020 and 2021
Table 94. Micronit Microtechnologies B.V. Recent Development
Table 95. Lung-on-a-chip Market Trends
Table 96. Lung-on-a-chip Market Drivers
Table 97. Lung-on-a-chip Market Challenges
Table 98. Lung-on-a-chip Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung-on-a-chip Market Share by Type in 2021 & 2027
Figure 2. Pulmonary Inflammation Features
Figure 3. Pulmonary Infection Features
Figure 4. Global Lung-on-a-chip Market Share by Application in 2021 & 2027
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Other End Users Case Studies
Figure 8. Lung-on-a-chip Report Years Considered
Figure 9. Global Lung-on-a-chip Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global Lung-on-a-chip Market Share by Regions (2020-2027)
Figure 11. Global Lung-on-a-chip Market Share by Players in 2021
Figure 12. Global Lung-on-a-chip Market Size Market Share by Type (2021-2027)
Figure 13. Global Lung-on-a-chip Market Size Market Share by Application (2021-2027)
Figure 14. Global Lung-on-a-chip Revenue Market Share by Application in 2021
Figure 15. North America Lung-on-a-chip Market Size 2021-2027 (US$ Million)
Figure 16. Europe Lung-on-a-chip Market Size 2021-2027 (US$ Million)
Figure 17. Japan Lung-on-a-chip Market Size 2021-2027 (US$ Million)
Figure 18. Lung-on-a-chip Market Size in China (2021-2027) (US$ Million)
Figure 19. Lung-on-a-chip Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. Lung-on-a-chip Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年） Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD.Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Market Analysis and Insights: Global Lung Pulmonary Airway Disease…- 世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の間質性肺疾患（ILD）市場規模・現状・予測（2021年-2027年） Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
- 世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…